Europe Male Infertility Market Forecast 2023-2032

The Europe male infertility market is projected to propel with a 4.29% CAGR between the forecast years 2023 to 2032. Widespread adoption of affordable therapies and devices, increased utilization of assisted reproductive technologies, reimbursement coverages, presence of key market players, large patient base, R&D investments, and EMA approvals drive market growth.

MARKET INSIGHTS

The Europe male infertility market growth evaluation includes a thorough study of Belgium, France, Germany, Poland, Spain, the United Kingdom, Italy, and Rest of Europe. Male infertility problems in France are expected to be boosted by high infertility rates, increasing prevalence of diabetes and lifestyle-related diseases, growing stress levels, increasing smoking rates, and rising cases of prostate cancer. Moreover, the increasing prevalence of diabetes in France further negatively impacts male fertility, with an expected rise in the number of diabetes cases by 2030 and 2045.

In Italy, the male infertility market is expected to expand due to increasing cases of male infertility related to lifestyle changes, diet, pollution, stress, and obesity. Stress, anxiety, and health issues also contribute to the market dynamics. The incidence of prostate cancer is rising in Italy, impacting sperm motility due to inflammation and bladder issues. A study reveals a decline in male fertility compared to female fertility, with socioeconomic status playing a significant role. Additionally, moderate alcohol consumption positively correlates with semen volume, sperm concentration, and total sperm count. These factors are anticipated to drive the market growth in Italy.

COMPETITIVE INSIGHTS

Key companies are: Endo International PLC, Andrology Solutions, Vitrolife, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 51584

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. PRODUCT DEVELOPMENTS AND LAUNCHES BY MARKET PLAYERS PROMOTE MARKET GROWTH
- 2.5.2. PREVALENCE OF DIABETES AND CANCER

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. SURGING INFERTILITY INCIDENCES
- 3.1.2. ASSISTED REPRODUCTIVE TECHNOLOGY ADOPTION
- 3.1.3. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
- 3.2.1. HIGH TREATMENT COSTS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS

5. MARKET BY TEST TYPE

5.1. DNA FRAGMENTATION TECHNIQUE
5.2. OXIDATIVE STRESS ANALYSIS
5.3. MICROSCOPIC EXAMINATION
5.4. SPERM AGGLUTINATION
5.5. COMPUTER-ASSISTED SEMEN ANALYSIS
5.6. SPERM PENETRATION ASSAY
5.7. OTHER TEST TYPES

6. MARKET BY TREATMENT

6.1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY
6.2. MEDICATIONS

7. GEOGRAPHICAL ANALYSIS

7.1. EUROPE
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. EUROPE MALE INFERTILITY MARKET DRIVERS
- 7.1.3. EUROPE MALE INFERTILITY MARKET CHALLENGES
- 7.1.4. KEY PLAYERS IN EUROPE MALE INFERTILITY MARKET
- 7.1.5. COUNTRY ANALYSIS
  - 7.1.5.1. UNITED KINGDOM
  - 7.1.5.1.1. UNITED KINGDOM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.2. GERMANY
  - 7.1.5.2.1. GERMANY MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.3. FRANCE
  - 7.1.5.3.1. FRANCE MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.4. ITALY
  - 7.1.5.4.1. ITALY MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.5. SPAIN
  - 7.1.5.5.1. SPAIN MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.6. BELGIUM
  - 7.1.5.6.1. BELGIUM MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.7. POLAND
  - 7.1.5.7.1. POLAND MALE INFERTILITY MARKET SIZE & OPPORTUNITIES
  - 7.1.5.8. REST OF EUROPE
  - 7.1.5.8.1. REST OF EUROPE MALE INFERTILITY MARKET SIZE & OPPORTUNITIES

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. MERGERS & ACQUISITIONS
- 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 8.1.3. PARTNERSHIPS & AGREEMENTS
- 8.1.4. BUSINESS EXPANSIONS
8.2. COMPANY PROFILES
- 8.2.1. ADVACARE PHARMA USA
  - 8.2.1.1. COMPANY OVERVIEW
  - 8.2.1.2. PRODUCTS / SERVICES LIST
- 8.2.2. ANDROLOGY SOLUTIONS
  - 8.2.2.1. COMPANY OVERVIEW
  - 8.2.2.2. PRODUCTS / SERVICES LIST
- 8.2.3. AYTU BIOPHARMA
  - 8.2.3.1. COMPANY OVERVIEW
  - 8.2.3.2. PRODUCTS / SERVICES LIST
  - 8.2.3.3. STRENGTHS & CHALLENGES
- 8.2.4. BAYER GROUP
  - 8.2.4.1. COMPANY OVERVIEW
  - 8.2.4.2. PRODUCTS / SERVICES LIST
  - 8.2.4.3. STRENGTHS & CHALLENGES
- 8.2.5. CAERUS BIOTECH
  - 8.2.5.1. COMPANY OVERVIEW
  - 8.2.5.2. PRODUCTS / SERVICES LIST
- 8.2.6. CINNAGEN CO
  - 8.2.6.1. COMPANY OVERVIEW
  - 8.2.6.2. PRODUCTS / SERVICES LIST
  - 8.2.6.3. STRENGTHS & CHALLENGES
- 8.2.7. EMD SERONO INC (MERCK SERONO)
  - 8.2.7.1. COMPANY OVERVIEW
  - 8.2.7.2. PRODUCTS / SERVICES LIST
  - 8.2.7.3. STRENGTHS & CHALLENGES
- 8.2.8. ENDO INTERNATIONAL PLC
  - 8.2.8.1. COMPANY OVERVIEW
  - 8.2.8.2. PRODUCTS / SERVICES LIST
  - 8.2.8.3. STRENGTHS & CHALLENGES
- 8.2.9. HALOTECH DNA
  - 8.2.9.1. COMPANY OVERVIEW
  - 8.2.9.2. PRODUCTS / SERVICES LIST
- 8.2.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
  - 8.2.10.1. COMPANY OVERVIEW
  - 8.2.10.2. PRODUCTS / SERVICES LIST
  - 8.2.10.3. STRENGTHS & CHALLENGES
- 8.2.11. SANOFI
  - 8.2.11.1. COMPANY OVERVIEW
  - 8.2.11.2. PRODUCTS / SERVICES LIST
  - 8.2.11.3. STRENGTHS & CHALLENGES
- 8.2.12. SCSA DIAGNOSTICS
  - 8.2.12.1. COMPANY OVERVIEW
  - 8.2.12.2. PRODUCTS / SERVICES LIST
- 8.2.13. THERAMEX
  - 8.2.13.1. COMPANY OVERVIEW
  - 8.2.13.2. PRODUCTS / SERVICES LIST
- 8.2.14. VITROLIFE
  - 8.2.14.1. COMPANY OVERVIEW
  - 8.2.14.2. PRODUCTS / SERVICES LIST
  - 8.2.14.3. STRENGTHS & CHALLENGES
- 8.2.15. ZYDUS LIFESCIENCES LTD (CADILA HEALTHCARE LTD)
  - 8.2.15.1. COMPANY OVERVIEW
  - 8.2.15.2. PRODUCTS / SERVICES LIST
  - 8.2.15.3. STRENGTHS & CHALLENGES

Product Code: 51584

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - MALE INFERTILITY
TABLE 2: EUROPE MALE INFERTILITY MARKET, BY TEST TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: EUROPE MALE INFERTILITY MARKET, BY TEST TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: EUROPE MALE INFERTILITY MARKET, BY TREATMENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: EUROPE TREATMENT MARKET, BY TREATMENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: EUROPE MALE INFERTILITY MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: EUROPE MALE INFERTILITY MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: KEY PLAYERS OPERATING IN EUROPE MALE INFERTILITY MARKET
TABLE 9: LIST OF MERGERS & ACQUISITIONS
TABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 11: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 12: LIST OF BUSINESS EXPANSIONS

LIST OF FIGURES

FIGURE 1: PORTER'S FIVE FORCES ANALYSIS
FIGURE 2: GROWTH PROSPECT MAPPING
FIGURE 3: MARKET MATURITY ANALYSIS
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: EUROPE MALE INFERTILITY MARKET, GROWTH POTENTIAL, BY TEST TYPE, IN 2022
FIGURE 6: EUROPE MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)
FIGURE 7: EUROPE MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2032 (IN $ MILLION)
FIGURE 8: EUROPE MALE INFERTILITY MARKET, BY OXIDATIVE STRESS ANALYSIS, 2023-2032 (IN $ MILLION)
FIGURE 9: EUROPE MALE INFERTILITY MARKET, BY MICROSCOPIC EXAMINATION, 2023-2032 (IN $ MILLION)
FIGURE 10: EUROPE MALE INFERTILITY MARKET, BY SPERM AGGLUTINATION, 2023-2032 (IN $ MILLION)
FIGURE 11: EUROPE MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2032 (IN $ MILLION)
FIGURE 12: EUROPE MALE INFERTILITY MARKET, BY SPERM PENETRATION ASSAY, 2023-2032 (IN $ MILLION)
FIGURE 13: EUROPE MALE INFERTILITY MARKET, BY OTHER TEST TYPES, 2023-2032 (IN $ MILLION)
FIGURE 14: EUROPE TREATMENT MARKET, GROWTH POTENTIAL, BY TREATMENT, IN 2022
FIGURE 15: EUROPE MALE INFERTILITY MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2032 (IN $ MILLION)
FIGURE 16: EUROPE MALE INFERTILITY MARKET, BY MEDICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 17: EUROPE MALE INFERTILITY MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 18: UNITED KINGDOM MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 19: GERMANY MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 20: FRANCE MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 21: ITALY MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: SPAIN MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: BELGIUM MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: POLAND MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: REST OF EUROPE MALE INFERTILITY MARKET, 2023-2032 (IN $ MILLION)